EUVIMEDEUVIMED entdecken
Crossref

Upregulation of KIF18A is associated with poor prognosis and immune alterations in kidney renal papillary cell carcinoma

Wanyu Dong, Rong Wei, Rushuang Deng, Daru Lu, Yanqiu Zhang

American Journal of Clinical and Experimental Immunology · 2026 · 15 (5) · 383-397

DOI: 10.62347/jvmv3248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Clinical and Experimental Immunology, 2026. Verfasst von Wanyu Dong und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Dong, W., Wei, R., Deng, R., Lu, D., & Zhang, Y. (2026). Upregulation of KIF18A is associated with poor prognosis and immune alterations in kidney renal papillary cell carcinoma. American Journal of Clinical and Experimental Immunology, 15(5), 383-397. https://doi.org/10.62347/jvmv3248

Vancouver

Dong W, Wei R, Deng R, Lu D, Zhang Y. Upregulation of KIF18A is associated with poor prognosis and immune alterations in kidney renal papillary cell carcinoma. American Journal of Clinical and Experimental Immunology. 2026;15(5):383-397. doi:10.62347/jvmv3248

BibTeX
@article{Dong2026,
  author = {Dong, Wanyu and Wei, Rong and Deng, Rushuang and Lu, Daru and Zhang, Yanqiu},
  title = {Upregulation of KIF18A is associated with poor prognosis and immune alterations in kidney renal papillary cell carcinoma},
  journal = {American Journal of Clinical and Experimental Immunology},
  year = {2026},
  volume = {15},
  number = {5},
  pages = {383--397},
  doi = {10.62347/jvmv3248}
}
Kostenlos starten →